Author:
Miyagawa Koichi,Rösch Josef,Stanczyk Frank,Hermsmeyer Kent
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference23 articles.
1. Gorodeski, G.I. & Utian, W.H. Epidemiology and risk factors of cardiovascular disease in postmenopausal women, in Treatment of the PostmenopausalWoman: Basic and Clinical Aspects (ed. Lobo, R.A.) 199–221 (Raven, New York, 1994).
2. Wenger, N.K., Speroff, L. & Packard, B. Cardiovascular health and disease in women. New Engl. J. Med. 329, 247–256 (1993).
3. The writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women, the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273, 199–208 (1995).
4. Lobo, R.A., Pickar, J.H., Wild, R.A., Walsh, B. & Hirvonen, E. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. Obstet. Cynecol. 84, 987–995 (1994).
5. Poulter, N.R. Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study. Lancet 346, 1575–1582 (1995).
Cited by
225 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献